Nomura Asset Management
ARIA

Nomura Asset Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Nomura Asset Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-50,000
Closed -$270K – 905
2014
Q3 		$270K Hold
50,000
– – ﹤0.01% 824
2014
Q2 		$319K Hold
50,000
– – 0.01% 805
2014
Q1 		$403K Buy
+50,000
New +$389K 0.01% 793

Other funds holding ARIA

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nomura Asset Management's ARIA Position: Q4 2014 in Review

Nomura Asset Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2014, closing a stake of 50,000 shares — an estimated $270K sold.

Nomura Asset Management first reported a position in ARIA in Q1 2014 and held it in 3 quarters. The position peaked at $403K in Q1 2014. 179 funds tracked by Wall St. Rank hold ARIA as of Q4 2014.

  • Nomura Asset Management reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2014 after selling out during the quarter.
  • Nomura Asset Management sold 50,000 Ariad Pharmaceuticals Inc shares in Q4 2014, an estimated $270K.
  • Nomura Asset Management first reported a position in Ariad Pharmaceuticals Inc in Q1 2014 and held it in 3 quarters.
  • Nomura Asset Management's Ariad Pharmaceuticals Inc position peaked at $403K in Q1 2014.
  • 179 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2014.

Based on Nomura Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.